ÇÐÁ¦°£¿¬±¸ | Interdisciplinary Studies in Gambling | Î¥学Ρ研ϼ
- Article] Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions
-
DocNo of ILP: 46
Doc. Type: Article
Title: Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions
Authors: Matza, LS; Boye, KS; Feeny, DH; Johnston, JA; Bowman, L; Jordan, JB
Full Name of Authors: Matza, Louis S.; Boye, Kristina S.; Feeny, David H.; Johnston, Joseph A.; Bowman, Lee; Jordan, Jessica B.
Keywords by Author: Utility; Time trade-off; Standard gamble; Caregiver; Parenting; Cost-utility
Keywords Plus: COST-EFFECTIVENESS ANALYSIS; TEST-RETEST RELIABILITY; CANCER-PATIENTS; VALUATIONS; FEASIBILITY; PREFERENCES; VALUES; LIFE
Abstract: Background: The purpose of this study was to examine the effect of caregiver status on time trade-off (TTO) and standard gamble (SG) health state utility scores. Respondents were categorized as caregivers if they reported that either children or adults depended on them for care. Methods: This study was a secondary analysis of data from three studies in which general population samples rated health state descriptions. Study 1: UK; four osteoarthritis health states. Study 2: UK; three adult ADHD health states. Study 3: US; 16 schizophrenia health states. All three studies included time trade-off assessment. Study 1 also included standard gamble. Descriptive statistics were calculated to examine willingness to trade in TTO or gamble in SG. Utilities for caregivers and non-caregivers were compared using t-tests and ANCOVA models. Results: There were 364 respondents including 106 caregivers (n = 30, 47, and 29 in Studies 1, 2, and 3) and 258 non-caregivers. Most caregivers were parents of dependent children (78.3%). Compared to non-caregivers, caregivers had more responses at the ceiling (i.e., utility = 0.95), indicating less willingness to trade time or gamble. All utilities were higher for caregivers than non-caregivers (mean utility difference between groups: 0.07 to 0.16 in Study 1 TTO; 0.03 to 0.17 in Study 1 SG; 0.06 to 0.10 in Study 2 TTO; 0.11 to 0.22 in Study 3 TTO). These differences were statistically significant for at least two health states in each study (p < 0.05). Results of sensitivity analyses with two caregiver subgroups (parents of dependent children and parents of any child regardless of whether the child was still dependent) followed the same pattern as results of the primary analysis. The parent subgroups were generally less willing to trade time or gamble (i.e., resulting in higher utility scores) than comparison groups of non-parents. Conclusions: Results indicate that caregiver status, including being a parent, influences responses in time trade-off health state valuation. Caregivers (i.e., predominantly parents) were less willing than non-caregivers to trade time, resulting in higher utility scores. This pattern was consistent across multiple health states in three studies. Standard gamble results followed similar patterns, but with less consistent differences between groups. It may be useful to consider parenting/caregiving status when collecting, interpreting, or using utility data because this demographic variable could influence results.
Cate of OECD: Health sciences
Year of Publication: 2014
Business Area: other
Detail Business: medicine & science
Country: England
Study Area: patient, preference, cancer
Name of Journal: HEALTH AND QUALITY OF LIFE OUTCOMES
Language: English
Country of Authors: [Matza, Louis S.; Jordan, Jessica B.] Evidera, Outcomes Res, Bethesda, MD USA; [Boye, Kristina S.] Eli Lilly & Co, Global Hlth Outcomes, Diabet, Indianapolis, IN 46285 USA; [Feeny, David H.] Univ Alberta, Dept Econ, Edmonton, AB T6G 2E1, Canada; [Johnston, Joseph A.] Eli Lilly & Co, Global Hlth Outcomes, Indianapolis, IN 46285 USA; [Bowman, Lee] Eli Lilly & Co, Global Hlth Outcomes, Oncol, Indianapolis, IN 46285 USA
Press Adress: Matza, LS (reprint author), Evidera, Outcomes Res, Bethesda, MD USA.
Email Address: louis.matza@evidera.com
Citaion:
Funding: Eli Lilly Co.
Lists of Citation: ASHBY J, 1994, QUAL LIFE RES, V3, P257, DOI 10.1007/BF00434899; Badia X, 1999, QUAL LIFE RES, V8, P303, DOI 10.1023/A:1008952423122; Baker R, 2004, HEALTH ECON, V13, P37, DOI 10.1002/hec.795; Basu A, 2005, J HEALTH ECON, V24, P751, DOI 10.1016/j.jhealco.2004.12.002; Brazier J, 2007, MEASURING VALUING HL; Brazier J, 2008, PHARMACOECONOMICS, V26, P769, DOI 10.2165/00019053-200826090-00007; Bursztajn H, 1982, Med Decis Making, V2, P161, DOI 10.1177/0272989X8200200207; Dolan P, 2002, SOC SCI MED, V54, P919, DOI 10.1016/S0277-9536(01)00066-1; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Feeny D, 2004, QUAL LIFE RES, V13, P15, DOI 10.1023/B:QURE.0000015307.33811.2d; Feeny D, 2005, ASSESSING QUALITY LI, P405; Hazen GB, 2009, MED DECIS MAKING, V29, P580, DOI 10.1177/0272989X09333121; LAUPACIS A, 1993, J BONE JOINT SURG AM, V75A, P1619; Mrus JM, 2006, MED CARE, V44, P158, DOI 10.1097/01.mlr.0000197027.06808.e2; NICE (National Institute for Health and Clinical Excellence), 2013, GUID METH TECHN APPR; PBAC (Pharmaceutical Benefits Advisory Committee), 2008, GUID PREP SUBM PBAC; Prosser LA, 2007, PHARMACOECONOMICS, V25, P713, DOI 10.2165/00019053-200725090-00001; Rosen AB, 2003, MED DECIS MAKING, V23, P511, DOI 10.1177/0272989X03258431; Rowen D, 2011, OXFORD HDB HLTH EC, P788; STIGGELBOUT AM, 1995, J CLIN EPIDEMIOL, V48, P1207, DOI 10.1016/0895-4356(95)00011-R; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Torrance George W, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P99, DOI 10.1586/14737167.2.2.99; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Ungar WJ, 2011, PHARMACOECONOMICS, V29, P641, DOI 10.2165/11591570-000000000-00000; van der Pol M, 2007, MED DECIS MAKING, V27, P406, DOI 10.1177/0272989X07302127; van Nooten FE, 2009, HEALTH ECON, V18, P549, DOI 10.1002/hec.1385; Yi MS, 2009, J PEDIATR, V154, P527, DOI 10.1016/j.jpeds.2008.10.003
Number of Citaion: 27
Publication: BIOMED CENTRAL LTD
City of Publication: LONDON
Address of Publication: 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
ISSN: 1477-7525
29-Character Source Abbreviation: HEALTH QUAL LIFE OUT
ISO Source Abbreviation: Health Qual. Life Outcomes
Volume: 12
Version:
Start of File:
End of File:
DOI: 10.1186/1477-7525-12-48
Number of Pages: 11
Web of Science Category: Health Care Sciences & Services; Health Policy & Services
Subject Category: Health Care Sciences & Services
Document Delivery Number: AG2OW
Unique Article Identifier: WOS:000335256900001
- reply : 0
-
- list
-
- prev
- next